Literature DB >> 30925392

Quantifying the public's view on social value judgments in vaccine decision-making: A discrete choice experiment.

Jeroen Luyten1, Roselinde Kessels2, Katherine E Atkins3, Mark Jit4, Albert Jan van Hoek5.   

Abstract

Vaccination programs generate direct protection, herd protection and, occasionally, side effects, distributed over different age groups. This study elicits the general public's view on how to balance these outcomes in funding decisions for vaccines. We performed an optimal design discrete choice experiment with partial profiles in a representative sample (N = 1499) of the population in the United Kingdom in November 2016. Using a panel mixed logit model, we quantified, for four different types of infectious disease, the importance of a person's age during disease, how disease was prevented-via direct vaccine protection or herd protection-and whether the vaccine induced side effects. Our study shows clear patterns in how the public values vaccination programs. These diverge from the assumptions made in public health and cost-effectiveness models that inform decision-making. We found that side effects and infections in newborns and children were of primary importance to the perceived value of a vaccination program. Averting side effects was, in any age group, weighted three times as important as preventing an identical natural infection in a child whereas the latter was weighted six times as important as preventing the same infection in elderly aged 65-75 years. These findings were independent of the length or severity of the disease, and were robust across respondents' backgrounds. We summarize these patterns in a set of preference weights that can be incorporated into future models. Although the normative significance of these weights remains a matter open for debate, our study can, hopefully, contribute to the evaluation of vaccination programs beyond cost-effectiveness.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Age; Cost-effectiveness analysis; Decision making; Equity; Herd immunity; Priority-setting; Side effects; United Kingdom

Mesh:

Year:  2019        PMID: 30925392     DOI: 10.1016/j.socscimed.2019.03.025

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  9 in total

1.  Social Causes of Vaccine Rejection-Vaccine Indecision Attitudes in the Context of Criticisms of Modernity.

Authors:  Ali Ergur
Journal:  Eurasian J Med       Date:  2020-06

2.  An assessment of the vaccination of school-aged children in England against SARS-CoV-2.

Authors:  Matt J Keeling; Sam E Moore
Journal:  BMC Med       Date:  2022-05-18       Impact factor: 11.150

3.  What drives willingness to receive a new vaccine that prevents an emerging infectious disease? A discrete choice experiment among university students in Uganda.

Authors:  Kimberly E Bonner; Henry Ssekyanzi; Jonathan Sicsic; Judith E Mueller; Traci Toomey; Angela K Ulrich; Keith J Horvath; James D Neaton; Cecily Banura; Nicole E Basta
Journal:  PLoS One       Date:  2022-05-19       Impact factor: 3.752

4.  Preference of influenza vaccination among the elderly population in Shaanxi province, China.

Authors:  Minghuan Jiang; Pengchao Li; Xuelin Yao; Khezar Hayat; Yilin Gong; Shan Zhu; Jin Peng; Xinke Shi; Zhaojing Pu; Yifan Huang; Yu Fang
Journal:  Hum Vaccin Immunother       Date:  2021-05-05       Impact factor: 3.452

5.  Mortality reduction benefits and intussusception risks of rotavirus vaccination in 135 low-income and middle-income countries: a modelling analysis of current and alternative schedules.

Authors:  Andrew Clark; Jacqueline Tate; Umesh Parashar; Mark Jit; Mateusz Hasso-Agopsowicz; Nicholas Henschke; Benjamin Lopman; Kevin Van Zandvoort; Clint Pecenka; Paul Fine; Colin Sanderson
Journal:  Lancet Glob Health       Date:  2019-11       Impact factor: 26.763

Review 6.  Inclusion of Safety-Related Issues in Economic Evaluations for Seasonal Influenza Vaccines: A Systematic Review.

Authors:  Tanja Fens; Pieter T de Boer; Eugène P van Puijenbroek; Maarten J Postma
Journal:  Vaccines (Basel)       Date:  2021-02-02

7.  Rationing of a scarce life-saving resource: Public preferences for prioritizing COVID-19 vaccination.

Authors:  Jeroen Luyten; Sandy Tubeuf; Roselinde Kessels
Journal:  Health Econ       Date:  2021-11-17       Impact factor: 2.395

8.  Accounting for indirect protection in the benefit-risk ratio estimation of rotavirus vaccination in children under the age of 5 years, France, 2018.

Authors:  Sylvie Escolano; Judith E Mueller; Pascale Tubert-Bitter
Journal:  Euro Surveill       Date:  2020-08

9.  Value Frameworks for Vaccines: Which Dimensions Are Most Relevant?

Authors:  Jeroen Luyten; Roselinde Kessels; Corinne Vandermeulen; Philippe Beutels
Journal:  Vaccines (Basel)       Date:  2020-10-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.